US FDA approved a generic version of Advair Diskus

Respirent Pharmaceuticals and Lannett received final approval from the US FDA for a Generic version of Advair Diskus. Please see announcement by CNBC TV18https://www.cnbctv18.com/market/usfda-nod-for-advair-generic-positive-for-aurobindo-pharma-but-negative-for-cipla-here-is-why-19819787.htm All Studies (Therapeutic Equivalence-Bioequivalence study with Clinical Endpoints and Bioequivalence studies with Pharmacokinetic Endpoints) were conducted by BECRO. This shows the efficiency and reliability of BECRO in conducting successful studies. BECRO

Read More

Invitation to BECRO’s Stand 9.2C82 at CPhI Frankfurt 2025

BECRO is participating as Exhibitor in CPhI Frankfurt 2025 (October 28-30), Stand 9.2C82. BECRO is specialized in the conduct of Therapeutic Equivalent (Non-Inferiority) studies (Bioequivalence studies with Clinical End-points) for Topical Generic products: Bioequivalence-Pharmacokinetic studies. Superiority studies for Generic products. Clinical investigations for Medical Devices. BECRO offers clinical trials services all the way from study

Read More

Another successful US FDA Inspection with Positive Outcome

Recently, US FDA Inspected BECRO for one more time, and the Outcome of the Inspection was again Positive with No Observations. The aim of the FDA Inspection was to determine whether the activities and procedures of BECRO complied with 21 CFR Part 320 – Bioavailability and Bioequivalence (BE). In particular, FDA conducted this inspection to

Read More

Invitation to BECRO’s Stand 24D44 at CPhI Milan 2024

BECRO is participating as Exhibitor at CPhI Milan 2024 (8-10 October), Stand 24D44. BECRO is specialized in the conduct of BECRO offers clinical trials services all the way from study set up to submission. In addition, BECRO specializes in drafting modules of CDT and CERs for Medical Devices, and in preparing CDT and CDISC for

Read More

Invitation to BECRO’s Stand at CPhI Barcelona 2023

CPhI Barcelona 2023 BECRO is participating as Exhibitor at CPhI Barcelona 2023 (24-26 October), Stand 80E40, zone API. BECRO offers clinical trials services all the way from study set up to submission. In addition, BECRO specializes in drafting modules of CDT and CERs for Medical Devices, and in preparing CDT and CDISC for US FDA submissions. BECRO was

Read More

Invitation to BECRO’s Stand at CPhI Frankfurt 2022

BECRO is participating as Exhibitor at CPhI Worldwide Frankfurt 2022 (1-3 November), Stand 91A68, Hall 9.1. BECRO offers clinical trials services all the way from study set up to submission. In addition, BECRO specializes in drafting modules of CDT and CERs for Medical Devices, and in preparing CDT and CDISC for US FDA submissions. BECRO

Read More

FDA Inspected

BECRO Ltd was inspected by US FDA, recently, and the outcome of the inspection was positive

Accessibility Toolbar